Amaranth Medical, Inc. announced that it has received funding from Boston Scientific Corporation.
On January 14, 2014, Amaranth Medical, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.5 USD | -0.09% | -0.17% | +30.60% |
06-03 | Boston Scientific Insider Sold Shares Worth $526,029, According to a Recent SEC Filing | MT |
05-31 | Boston Scientific Insider Sold Shares Worth $4,791,447, According to a Recent SEC Filing | MT |
1st Jan change | Capi. | |
---|---|---|
+30.60% | 111B | |
+7.31% | 217B | |
+12.99% | 190B | |
+19.71% | 143B | |
+0.65% | 64.59B | |
+15.23% | 52.36B | |
+2.06% | 48.45B | |
-5.49% | 38.03B | |
-0.22% | 35.6B | |
+20.56% | 30.31B |